|
1
|
RECOVERY Collaborative Group. Convalescent
plasma in patients admitted to hospital with COVID-19 (RECOVERY): A
randomised controlled, open-label, platform trial. Lancet.
397:2049–2059. 2021.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Bégin P, Callum J, Heddle NM, Cook R,
Zeller MP, Tinmouth A, Fergusson DA, Cushing MM, Glesby MJ, Chassé
M, Devine DV, et al: Convalescent plasma for adults with acute
COVID-19 respiratory illness (CONCOR-1): Study protocol for an
international, multicentre, randomized, open-label trial. Trials.
22(323)2021.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Angus DC, Berry S, Lewis RJ, Al-Beidh F,
Arabi Y, van Bentum-Puijk W, Bhimani Z, Bonten M, Broglio K,
Brunkhorst F, et al: The REMAP-CAP (randomized embedded
multifactorial adaptive platform for community-acquired pneumonia)
study. Rationale and design. Ann Am Thorac Soc. 17:879–891.
2020.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Gudipati S, Brar I, Murray S, McKinnon JE,
Yared N and Markowitz N: Descriptive analysis of patients living
with HIV affected by COVID-19. J Acquir Immune Defic Syndr.
85:123–126. 2020.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Karmen-Tuohy S, Carlucci PM, Zervou FN,
Zacharioudakis IM, Rebick G, Klein E, Reich J, Jones S and Rahimian
J: Outcomes among HIV-positive patients hospitalized with COVID-19.
J Acquir Immune Defic Syndr. 85:6–10. 2020.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Nagarakanti SR, Okoh AK, Grinberg S and
Bishburg E: Clinical outcomes of patients with COVID-19 and HIV
coinfection. J Med Virol. 93:1687–1693. 2021.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Shalev N, Scherer M, LaSota ED, Antoniou
P, Yin MT, Zucker J and Sobieszczyk ME: Clinical characteristics
and outcomes in people living with Human Immunodeficiency Virus
hospitalized for COVID-19. Clin Infect Dis. 71:2294–2297.
2020.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Sigel K, Swartz T, Golden E, Paranjpe I,
Somani S, Richter F, De Freitas JK, Miotto R, Zhao S, Polak P, et
al: COVID-19 and people with HIV infection: Outcomes for
hospitalized patients in New York City. Clin Infect Dis.
71:2933–2938. 2020.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Bhaskaran K, Rentsch CT, MacKenna B,
Schultze A, Mehrkar A, Bates CJ, Eggo RM, Morton CE, Bacon SCJ,
Inglesby P, et al: HIV infection and COVID-19 death: A
population-based cohort analysis of UK primary care data and linked
national death registrations within the OpenSAFELY platform. Lancet
HIV. 8:e24–e32. 2021.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Calza L, Bon I, Tadolini M, Borderi M,
Colangeli V, Badia L, Verucchi G, Rossini G, Vocale C, Gaibani P,
et al: COVID-19 in patients with HIV-1 infection: A single-centre
experience in northern Italy. Infection. 49:333–337.
2021.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Childs K, Post FA, Norcross C, Ottaway Z,
Hamlyn E, Quinn K, Juniper T and Taylor C: Hospitalized patients
with COVID-19 and human immunodeficiency virus: A case series. Clin
Infect Dis. 71:2021–2022. 2020.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Collins LF, Moran CA, Oliver NT, Moanna A,
Lahiri CD, Colasanti JA, Kelley CF, Nguyen ML, Marconi VC,
Armstrong WS, et al: Clinical characteristics, comorbidities and
outcomes among persons with HIV hospitalized with coronavirus
disease 2019 in Atlanta, Georgia. AIDS. 34(1789)2020.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Joyner MJ, Bruno KA, Klassen SA, Kunze KL,
Johnson PW, Lesser ER, Wiggins CC, Senefeld JW, Klompas AM, Hodge
DO, et al: Safety update: COVID-19 convalescent plasma in 20,000
hospitalized patients. Mayo Clin Proc. 95:1888–1897.
2020.PubMed/NCBI View Article : Google Scholar
|
|
14
|
Laracy J, Zucker J, Castor D, McMahon DJ,
Guo TW, Yan M, Shalev N, Scherer M, Gordon P, Sobieszczyk M and Yin
MT: HIV-1 infection does not change disease course or inflammatory
pattern of SARS-CoV-2-infected patients presenting at a large urban
medical center in New York City. Open Forum Infect Dis.
8(ofab029)2021.PubMed/NCBI View Article : Google Scholar
|
|
15
|
Li L, Zhang W, Hu Y, Tong X, Zheng S, Yang
J, Kong Y, Ren L, Wei Q, Mei H, et al: Effect of convalescent
plasma therapy on time to clinical improvement in patients with
severe and life-threatening COVID-19: A randomized clinical trial.
JAMA. 324:460–470. 2020.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Patel VV, Felsen UR, Fisher M, Fazzari MJ,
Ginsberg MS, Beil R, Akiyama MJ, Anastos K and Hanna DB: Clinical
outcomes and inflammatory markers by HIV serostatus and viral
suppression in a large cohort of patients hospitalized with
COVID-19. J Acquir Immune Defic Syndr. 86:224–230. 2021.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Ridgway JP, Farley B, Benoit J-L, Frohne
C, Hazra A, Pettit N, Pho M, Pursell K, Saltzman J, Schmitt J, et
al: A case series of five people living with HIV hospitalized with
COVID-19 in Chicago, Illinois. AIDS Patient Care STDs. 34:331–335.
2020.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Ssentongo P, Heilbrunn ES, Ssentongo AE,
Advani S, Chinchilli VM, Nunez JJ and Du P: Prevalence of HIV in
patients hospitalized for COVID-19 and associated outcomes: A
systematic review and meta-analysis. medRxiv: Jul 6, 2020 (Epub
ahead of print). doi: doi.org/10.1101/2020.07.03.20143628.
|
|
19
|
Stoeckle K, Johnston CD, Jannat-Khah DP,
Williams SC, Ellman TM, Vogler MA, Gulick RM, Glesby MJ and Choi
JJ: COVID-19 in hospitalized adults with HIV. Open Forum Infect
Dis. 7(ofaa327)2020.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Vizcarra P, Pérez-Elías MJ, Quereda C,
Moreno A, Vivancos MJ, Dronda F and Casado JL: COVID-19 ID Team.
Description of COVID-19 in HIV-infected individuals: A
single-centre, prospective cohort. Lancet HIV. 7:e554–e64.
2020.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Malekifar P, Pakzad R, Shahbahrami R,
Zandi M, Jafarpour A, Rezayat SA, Akbarpour S, Shabestari AN,
Pakzad I, Hesari E, et al: Viral coinfection among COVID-19 PATIENT
groups: An update systematic review and meta-analysis. Biomed Res
Int. 3(2021)2021.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Health NIo: Coronavirus Disease 2019
(COVID-19) Treatment Guidelines. NIH, Bethesda, MD, 2020.
|
|
23
|
Hosseini P, Afzali S, Karimi M, Zandi M,
Zebardast A, Latifi T, Tabibzadeh A, Ramezani A, Zakeri A, Zakeri
A, et al: The coronavirus disease 2019 and effect on liver
function: A hidden and vital interaction beyond the respiratory
system. Rev Med Microbiol. 33:e161–e179. 2022.
|
|
24
|
Garg S, Kim L, Whitaker M, O'Halloran A,
Cummings C, Holstein R, Prill M, Chai SJ, Kirley PD, Alden NB, et
al: Hospitalization rates and characteristics of patients
hospitalized with laboratory-confirmed coronavirus disease
2019-COVID-NET, 14 States, March 1-30, 2020. MMWR Morb Mortal Wkly
Rep. 69(458)2020.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Soltani S, Zakeri A, Zandi M, Kesheh MM,
Tabibzadeh A, Dastranj M, Faramarzi S, Didehdar M, Hafezi H,
Hosseini P and Farahani A: The role of bacterial and fungal human
respiratory microbiota in COVID-19 patients. Biomed Res Int.
2021(6670798)2021.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Pakzad R, Malekifar P, Shateri Z, Zandi M,
Akhavan Rezayat S, Soleymani M, Karimi MR, Ahmadi SE, Shahbahrami
R, Pakzad I, et al: Worldwide prevalence of microbial agents'
coinfection among COVID-19 patients: A comprehensive updated
systematic review and meta-analysis. J Clin Lab Anal.
36(e24151)2022.PubMed/NCBI View Article : Google Scholar
|
